Results 301 to 310 of about 36,244 (312)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV

Vaccine, 2021
Mohammad Ali Sahraian, Fereshteh Ghadiri, Amirreza Azimi   +2 more
exaly  

Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)

Human Immunology, 2023
Ali H Ad'Hiah
exaly  

The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine

Frontiers in Immunology, 2022
Eman Farid, Nigel J Stevenson
exaly  

Two Cousins with Acute Hemichorea after BBIBP‐CorV (Sinopharm) COVID‐19 Vaccine

Movement Disorders, 2022
Mehri Salari, Masoud Etemadifar
exaly  

Corneal Allograft Endothelial Rejection after Sinopharm COVID-19 Vaccination; Report of Six Cases

Seminars in Ophthalmology, 2023
Yasaman Hadi, Parya Abdolalizadeh, Leila Ghiasian   +2 more
exaly  

Study the Effect of Sinopharm Vaccine on Apelin, Visfatin and Fertility in Men of Al Fallujah City

Bulletin of Pharmaceutical Sciences Assiut University
College of Applied Science second conference, Nazar Ahmed Naji, Hamed Ali Hamed   +2 more
semanticscholar   +1 more source

Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature

Journal of Cutaneous Pathology, 2022
Yousra Azzazi, Heba Ahmed Abdelkader, Mohamed H M El-Komy   +2 more
exaly  

Sinopharm Group Company Limited

2016
openaire   +1 more source

SKIN DEEP: UNDERSTANDING CUTANEOUS REACTIONS TO COVID-19 SINOPHARM VACCINE AND THEIR DERMATOLOGICAL IMPLICATIONS.

Journal of Population Therapeutics and Clinical
Khola Aijaz
semanticscholar   +1 more source

Toxidermie type exanthème maculo-papuleux secondaire au vaccin Sinopharm-CoronaVac®

Revue Francaise D'allergologie, 2022
exaly